chr16-56192353-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_020988.3(GNAO1):c.118G>A(p.Gly40Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 16/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G40A) has been classified as Pathogenic.
Frequency
Consequence
NM_020988.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020988.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNAO1 | NM_020988.3 | MANE Select | c.118G>A | p.Gly40Arg | missense splice_region | Exon 1 of 9 | NP_066268.1 | ||
| GNAO1 | NM_138736.3 | c.118G>A | p.Gly40Arg | missense splice_region | Exon 1 of 8 | NP_620073.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNAO1 | ENST00000262493.12 | TSL:1 MANE Select | c.118G>A | p.Gly40Arg | missense splice_region | Exon 1 of 9 | ENSP00000262493.6 | ||
| GNAO1 | ENST00000262494.13 | TSL:1 | c.118G>A | p.Gly40Arg | missense splice_region | Exon 1 of 8 | ENSP00000262494.7 | ||
| GNAO1 | ENST00000638705.1 | TSL:1 | c.118G>A | p.Gly40Arg | missense splice_region | Exon 1 of 8 | ENSP00000491223.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00 AC: 0AN: 245338 AF XY: 0.00
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 7.16e-7 AC: 1AN: 1396334Hom.: 0 Cov.: 25 AF XY: 0.00000143 AC XY: 1AN XY: 698062 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 17 Pathogenic:1
GNAO1-related disorder Pathogenic:1
The variant is observed at an extremely low frequency in the gnomAD v4.1.0 dataset (total allele frequency: <0.001%).Predicted Consequence/Location: The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense variant. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.98 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.97 (> 0.75, sensitivity 0.96 and precision 0.92)]. The same nucleotide change resulting in the same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000666297 / PMID: 26485252). Different missense changes at the same codon (p.Gly40Ala, p.Gly40Glu, p.Gly40Trp, p.Gly40Val) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000280526, VCV000280589, VCV000587482, VCV001802972 / PMID: 29390993, 30682224). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at